Skip to main content
Fig. 2 | BMC Gastroenterology

Fig. 2

From: C-reactive protein level at 2 weeks following initiation of infliximab induction therapy predicts outcomes in patients with ulcerative colitis: a 3 year follow-up study

Fig. 2

Receiver operating characteristic graphs to assess the significance of C-reactive protein (week 2/week 0) ratio for the prediction of infliximab partial-responder in patients with active ulcerative colitis undergoing infliximab-induction therapy. A cut-off value of 0.19 for C-reactive protein ratio on the receiver operating characteristic graph could predict infliximab partial-responder feature with a 79.1 % sensitivity and 75.9 % specificity

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us